purpose development novel carbon ion radiotherapy cirt treatment refractory cancers resulted need way accurately evaluate patient prognosis evaluated met uptake change cirt early survival predictors patients unresectable bone soft tissue sarcomas experimental design met positron emission tomography prospectively performed NUMBER patients unresectable bone soft tissue sarcomas NUMBER month cirt tumor met uptake measured semiquantitative tumornontumor ratio ratio met uptake tumor relevant clinical parameters entered univariate multivariate survival analysis results overall median survival time NUMBER months patients baseline ratio or6 significant better survival patients baseline ratio NUMBER survival rate NUMBER versus NUMBER p NUMBER patients ratio or44 better survival ratio NUMBER survival rate NUMBER versus NUMBER p NUMBER significant higher survival rate observed patients met uptake change NUMBER patients lower change group survival rate NUMBER versus NUMBER p NUMBER multivariate analysis showed baseline ratio statistically significant independent predictors patient survival tumors larger ratio significantly poorer prognosis conclusions met uptake measured baseline ratio independent predictor survival patients bone soft tissue sarcomas treated carbon ion radiotherapy met uptake change potential value purpose l methyl 11c methionine NUMBER year post cirt post cirt NUMBER year post therapeutic NUMBER year post cirt post cirt post therapeutic t n t n t n t n t n t n